HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiong Xu Selected Research

tripeptide tyroservatide

1/2011Effects of tyroservatide on histone acetylation in lung carcinoma cells.
10/2008[Evaluation of the inhibitory effect of tripeptide tyroservatide on growth of human hepatocellular carcinoma using a hollow fiber assay].
9/2008Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
1/2006Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiong Xu Research Topics

Disease

14Neoplasms (Cancer)
11/2021 - 01/2006
11Inflammation (Inflammations)
01/2022 - 01/2011
5Neoplasm Metastasis (Metastasis)
05/2022 - 01/2006
5Infections
01/2020 - 01/2018
4Atherosclerosis
11/2020 - 01/2020
4Breast Neoplasms (Breast Cancer)
01/2020 - 01/2018
4Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 03/2016
4Hepatocellular Carcinoma (Hepatoma)
08/2009 - 09/2008
3Acute Kidney Injury (Acute Renal Failure)
01/2022 - 01/2020
3Epilepsy (Aura)
07/2021 - 12/2020
3Autism Spectrum Disorder
01/2018 - 01/2016
2COVID-19
01/2022 - 01/2020
2Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 01/2020
2Fibrosis (Cirrhosis)
01/2021 - 01/2021
2Pneumonia (Pneumonitis)
01/2020 - 01/2020
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 01/2020
2Hypertension (High Blood Pressure)
02/2018 - 04/2007
2Liver Neoplasms (Liver Cancer)
03/2017 - 11/2008
2Autistic Disorder (Autism)
01/2016 - 08/2012
2Starvation
09/2014 - 05/2012
2Body Weight (Weight, Body)
07/2012 - 02/2008
2Carcinoma (Carcinomatosis)
01/2011 - 01/2006
2Essential Hypertension
03/2009 - 02/2009
2Pain (Aches)
02/2005 - 03/2004
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2022
1Reperfusion Injury
06/2022
1Cross Infection (Nosocomial Infection)
01/2022
1Vascular Remodeling
11/2021
1Neointima
11/2021
1Urinary Retention
06/2021
1Myopia
06/2021
1Prolapse
06/2021
1Pelvic Organ Prolapse
06/2021
1Encephalomalacia
01/2021
1Toxoplasmosis
01/2021
1Hypertrophy
01/2021
1Atrophy
01/2021
1Molar Hypomineralization
03/2020
1Aortic Dissection
01/2020

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
12/2021 - 08/2009
7CytokinesIBA
01/2022 - 01/2015
7Messenger RNA (mRNA)IBA
12/2019 - 08/2009
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 02/2008
4Glucose (Dextrose)FDA LinkGeneric
04/2017 - 02/2008
4tripeptide tyroservatideIBA
01/2011 - 01/2006
3Ubiquitin-Specific ProteasesIBA
06/2022 - 01/2021
3Therapeutic UsesIBA
06/2022 - 01/2006
3Deubiquitinating EnzymesIBA
11/2021 - 01/2020
3Pharmaceutical PreparationsIBA
01/2021 - 01/2016
3Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2011
3MicroRNAs (MicroRNA)IBA
01/2020 - 02/2018
3LipopolysaccharidesIBA
11/2019 - 01/2019
3Peptides (Polypeptides)IBA
01/2011 - 09/2008
2Oxygen (Dioxygen)IBA
06/2022 - 01/2015
2Proteasome Endopeptidase Complex (Proteasome)IBA
06/2022 - 01/2021
2Carrier Proteins (Binding Protein)IBA
05/2022 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2019
2Valproic Acid (Depakote)FDA LinkGeneric
07/2021 - 12/2020
2CD36 AntigensIBA
11/2020 - 01/2020
2Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 01/2020
2oxidized low density lipoproteinIBA
01/2020 - 07/2012
2Biological ProductsIBA
01/2020 - 12/2018
2Crystallins (Crystallin)IBA
01/2019 - 01/2015
2VancomycinFDA LinkGeneric
01/2019 - 01/2016
2Oxidoreductases (Dehydrogenase)IBA
12/2018 - 10/2018
2Long Noncoding RNAIBA
10/2017 - 03/2016
2tetramethylpyrazineIBA
01/2014 - 04/2011
2Thymidine Monophosphate (TMP)IBA
01/2014 - 04/2011
2Calcium HydroxideIBA
05/2012 - 04/2007
2H-Tyr-Ser-Leu-OHIBA
08/2009 - 11/2008
2ResistinIBA
03/2009 - 02/2009
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022
1Free RadicalsIBA
06/2022
1Hypoxia-Inducible Factor 1IBA
05/2022
1Chemokine CCL5IBA
05/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1NLR ProteinsIBA
01/2022
1GRB7 Adaptor ProteinIBA
12/2021
1Platelet Endothelial Cell Adhesion Molecule-1IBA
12/2021
1S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
11/2021
1Thomsen-Friedenreich antibodiesIBA
01/2021
1Volatile Oils (Essential Oils)IBA
01/2021
1Lactic Acid (Lactate)FDA LinkGeneric
01/2021
1UbiquitinIBA
01/2021
1salicylhydroxamic acid (SHAM)IBA
01/2021
1Aquaporin 5IBA
03/2020
1Aquaporins (Water Channels)IBA
03/2020
1CytosineIBA
01/2020
1Interleukin-10 (Interleukin 10)IBA
01/2020
1umifenovirIBA
01/2020

Therapy/Procedure

7Therapeutics
06/2021 - 01/2006
2Catheters
06/2021 - 01/2012
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020 - 01/2014
2Drug Therapy (Chemotherapy)
11/2008 - 09/2008
2Operative Time
02/2005 - 03/2004
1Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2022
1Lenses
01/2022
1Ligation
11/2021
1Urinary Catheters
06/2021
1Indwelling Catheters (Indwelling Catheter)
06/2021